CYP cynata therapeutics limited

Ann: Investor Presentation, page-186

  1. 4,867 Posts.
    lightbulb Created with Sketch. 344

    I think there has been some concern shown that manufacturing with IPSC's is probably not different than drug manufacturing as it is unnatural medicine, and it is a reproduced cell not in its natural state, that has been altered for the benefit of economic production and ease.


    That all sounds great as an investor, if you think that the FDA won't be sending that technology back for the next 20 years when they can't even get their head around natural cell technology.


    You know that these manufactured, or altered cells, are called pluripotent ( meaning many potentials ) indicating that whilst they may be good if proven over decades, they may also be very bad, like cell altering cancers, because they are manipulated.


    I can't see the FDA allowing this new technology for 20 years for CYP


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
17.0¢
Change
0.015(9.68%)
Mkt cap ! $38.41M
Open High Low Value Volume
15.5¢ 17.0¢ 15.5¢ $47.10K 289.1K

Buyers (Bids)

No. Vol. Price($)
1 50000 16.5¢
 

Sellers (Offers)

Price($) Vol. No.
17.0¢ 23813 3
View Market Depth
Last trade - 16.10pm 27/06/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.